Investigatorer i de placebokontrollerede kliniske forsøg skulle evaluere kliniske tegn (hudreaktioner) i henhold til protokollen.
Investigators of the placebo controlled clinical trials were required to evaluate protocol mandated clinical signs (skin reactions).